Results 121 to 130 of about 6,241 (179)

Predominant lung cDC2 phenotype in cigarette smoke-exposed mice favors polarization of IL-17-producing CD4⁺ T cells. [PDF]

Am J Physiol Lung Cell Mol Physiol
Mengistu DT, Toma MS, Anderson BC, Curtis JL, Freeman CM.   +4 more
europepmc   +1 more source

Dendritic cells in the lung cavities of extensively drug-resistant tuberculosis patients exhibit altered frequency and phenotype. [PDF]

ERJ Open Res
Londt R, Semple L, Pooran A, Esmail A, Davids M, Dheda K, Tomasicchio M.   +6 more
europepmc   +1 more source

Lactococcus lactis-HSP65 requires TLR2 to induce tolerogenic dendritic cells and confer protection against type 1 diabetes in a murine model. [PDF]

Cell Mol Life Sci
Elias-Oliveira J, Rodrigues VF, Pereira ÍS, Barbosa SC, Pereira JA, Pacheco TCF, Machado MSG, Masson AP, Rios WM, Gardinassi LG, Miyoshi A, Azevedo V, Silva CL, Tostes RC, Carlos D.   +14 more
europepmc   +1 more source

Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine. [PDF]

J Exp Med
Tam H, Shen H, Xu Y, An J, Cyster JG.
europepmc   +1 more source

Dendritic cells: the central partner for cancer immunity. [PDF]

Oncoimmunology
Laoubi L, Gobbini E, Duplouye P, Hubert M, Caux C, Bendriss-Vermare N, Valladeau-Guilemond J, Voissière A.   +7 more
europepmc   +1 more source

IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy. [PDF]

Cancer Immunol Res
Avanessian SC, van den Bijgaart RJE, Chew NW, Supper VM, Tang TT, Zhang Y, Zhao YQ, Abe K, Gauthier J, Barry KC.   +9 more
europepmc   +1 more source

Cohesin-mediated chromatin organization controls the differentiation and function of dendritic cells. [PDF]

Sci Immunol
Adams NM, Galitsyna A, Tiniakou I, Esteva E, Ra AC, Martinez-Krams D, Lau CM, Reyes J, Abdennur N, Shkolikov A, Yap GS, Khodadadi-Jamayran A, Dolgalev I, Mirny LA, Reizis B.   +14 more
europepmc   +1 more source

Antigen cross-presentation potentiating cancer vaccine adjuvant for T cell expansion and synergy with anti-PD-1. [PDF]

NPJ Vaccines
Dang GC, Loeurng V, Pa P, Seng CY, Lee SE, Rhee JH.   +5 more
europepmc   +1 more source

Reframing adjuvant immunotherapy in melanoma: all of it starts with priming. [PDF]

J Immunother Cancer
Ascierto PA, Melero I.
europepmc   +1 more source

In Situ Engineering of Tumor Cells as Self-Sustaining cDC1 Programming Factories for Effective Cancer Immunotherapy. [PDF]

Adv Sci (Weinh)
Jin S, Wang X, Li B, Zhu X, Liu Z, Lu J, Wei Y, Wu Z, Li K, Zhang T, He Z, Zhu P, Qi Y, Liu B, Liu H, Wang Y, Chen Z.   +16 more
europepmc   +1 more source